ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,182.96
-0.85%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,421.655
0.55%
Brent Oil
84.34
-0.30%
Bitcoin
64,896.50
6.76%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Poolbeg Pharma Plc (POLB)

  7. Poolbeg Pharma Plc (POLB) News

Poolbeg Pharma (POLB)

Poolbeg Pharma Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:POLB
DateTimeSourceHeadlineSymbolCompany
14/12/202207:00UK RegulatoryPoolbeg Pharma PLC Metabolic diseases oral delivery licence signedLSE:POLBPoolbeg Pharma Plc
12/12/202214:05UK RegulatoryPoolbeg Pharma PLC Second Price Monitoring ExtnLSE:POLBPoolbeg Pharma Plc
12/12/202214:00UK RegulatoryPoolbeg Pharma PLC Price Monitoring ExtensionLSE:POLBPoolbeg Pharma Plc
12/12/202207:00UK RegulatoryPoolbeg Pharma PLC POLB 001 LPS human challenge trial completedLSE:POLBPoolbeg Pharma Plc
02/12/202219:33Alliance NewsAlliance NewsTRADING UPDATES: Time Out eyes Riyadh; MTI Wireless wins dealLSE:POLBPoolbeg Pharma Plc
02/12/202219:33Alliance NewsAlliance NewsTRADING UPDATES: Time Out eyes Riyadh; MTI Wireless wins dealLSE:POLBPoolbeg Pharma Plc
29/11/202207:00RNS Non-RegulatoryPoolbeg Pharma PLC Influenza AI model build completedLSE:POLBPoolbeg Pharma Plc
18/11/202214:00UK RegulatoryPoolbeg Pharma PLC Price Monitoring ExtensionLSE:POLBPoolbeg Pharma Plc
17/11/202214:05UK RegulatoryPoolbeg Pharma PLC Second Price Monitoring ExtnLSE:POLBPoolbeg Pharma Plc
17/11/202214:00UK RegulatoryPoolbeg Pharma PLC Price Monitoring ExtensionLSE:POLBPoolbeg Pharma Plc
17/11/202207:00UK RegulatoryPoolbeg Pharma PLC Capital Markets DayLSE:POLBPoolbeg Pharma Plc
15/11/202217:25Alliance NewsAlliance NewsPoolbeg Pharma wins funding for oral vaccine developmentLSE:POLBPoolbeg Pharma Plc
15/11/202217:25Alliance NewsAlliance NewsPoolbeg Pharma wins funding for oral vaccine developmentLSE:POLBPoolbeg Pharma Plc
15/11/202210:36UK RegulatoryPoolbeg Pharma PLC Poolbeg-led consortium awarded EUR 2.3m grantLSE:POLBPoolbeg Pharma Plc
08/11/202212:18Alliance NewsAlliance NewsIN BRIEF: Poolbeg makes "significant breakthrough" in AI programmeLSE:POLBPoolbeg Pharma Plc
08/11/202212:18Alliance NewsAlliance NewsIN BRIEF: Poolbeg makes "significant breakthrough" in AI programmeLSE:POLBPoolbeg Pharma Plc
08/11/202207:00UK RegulatoryPoolbeg Pharma PLC AI programme yields novel RSV drug targetsLSE:POLBPoolbeg Pharma Plc
21/10/202207:00RNS Non-RegulatoryPoolbeg Pharma PLC Upcoming events participationLSE:POLBPoolbeg Pharma Plc
06/10/202216:40UK RegulatoryPoolbeg Pharma PLC Second Price Monitoring ExtnLSE:POLBPoolbeg Pharma Plc
06/10/202216:35UK RegulatoryPoolbeg Pharma PLC Price Monitoring ExtensionLSE:POLBPoolbeg Pharma Plc
06/10/202207:00UK RegulatoryPoolbeg Pharma PLC CEO Share PurchaseLSE:POLBPoolbeg Pharma Plc
04/10/202210:14Alliance NewsAlliance NewsPoolbeg expects formal patent grant soon to treat hypercytokinemiaLSE:POLBPoolbeg Pharma Plc
04/10/202210:14Alliance NewsAlliance NewsPoolbeg expects formal patent grant soon to treat hypercytokinemiaLSE:POLBPoolbeg Pharma Plc
04/10/202207:00UK RegulatoryPoolbeg Pharma PLC POLB 001 US Patent updateLSE:POLBPoolbeg Pharma Plc
27/09/202206:59Alliance NewsAlliance NewsIN BRIEF: Poolbeg Pharma teams up for Melioidosis vaccineLSE:POLBPoolbeg Pharma Plc
27/09/202206:59Alliance NewsAlliance NewsIN BRIEF: Poolbeg Pharma teams up for Melioidosis vaccineLSE:POLBPoolbeg Pharma Plc
21/09/202207:00UK RegulatoryPoolbeg Pharma PLC Poolbeg licence of Melioidosis vaccine candidateLSE:POLBPoolbeg Pharma Plc
12/09/202207:01RNS Non-RegulatoryPoolbeg Pharma PLC HC Wainwright Global Investment ConferenceLSE:POLBPoolbeg Pharma Plc
06/09/202214:05UK RegulatoryPoolbeg Pharma PLC Second Price Monitoring ExtnLSE:POLBPoolbeg Pharma Plc
06/09/202214:04Alliance NewsAlliance NewsIN BRIEF: Poolbeg shares rises on narrowed loss, strong pipelineLSE:POLBPoolbeg Pharma Plc
 Showing the most relevant articles for your search:LSE:POLB

Your Recent History

LSE
GDR
Genedrive
LSE
SOLG
Solgold
LSE
VAST
Vast Resources
LSE
SBTX
Skinbiotherapeutics
LSE
ENET
Ethernity Networks
LSE
AAZ
Anglo Asian Mining
LSE
LLOY
Lloyds Banking
LSE
CASP
Caspian Sunrise
LSE
ALTN
Altyngold
LSE
QBT
Quantum Blockchain Techn...
LSE
GKP
Gulf Keystone Petroleum
LSE
GSF
Gore Street Energy Storage
LSE
ZED
Zenova
LSE
CPX
Cap-xx
LSE
BP.
Bp
LSE
POS
Plexus
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved